The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims ...

Eli Lilly's weight-loss therapy Mounjaro became India's top-selling drug by value in October, data showed on Friday, ...

Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

Certain GLP-1 weight loss medications will be available for as little as $149 per month, a sharp drop from the current ...

Danish company vies with US drugmaker for control of Metsera as they seek edge in growing market for weight-loss drugs ...

The agreement, announced by the White House, potentially unlocks a major new market for the mega-blockbuster drugs.

Novo Nordisk A/S & Eli Lilly and Company cut prices for top diabetes drugs, boosting accessibility and potential revenue.

The stock price for Danish drugmaker Novo Nordisk (NYSE: NVO) is down more than 8% since last Friday's close. What's going on with this former darling of the global pharmaceutical industry that surged ...

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...

Trump secures a major deal with Eli Lilly and Novo Nordisk to cut obesity drug costs as Medicare expands coverage for ...

The announcement comes days after Democrats soundly defeated candidates from Trump’s Republican Party in a series of off-year ...

President Donald Trump announced major GLP-1 drug price cuts with Eli Lilly and Novo Nordisk, reducing costs for Ozempic and Wegovy.